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Introduction 
Gene editing (GE) technology is now widely used by plant scientists who work in a range of 
model and crop species. GARNet, The New Phytologist Trust and the Bristol Centre for 
Agricultural Innovation brought a group of global experts to the University of Bristol in March 
2018 to discuss current applications, emerging best practice and policy issues that surround use 
of this technology. 
 
Global legislation and gene editing in plants 
 
Difficult times in Europe 
 
One aim of the workshop was to discuss the regulatory and political issues that surround the 
use of GE. To this end, invited speakers explained developments from the regions of greatest 
relevance to delegates, namely the UK, other parts of Europe and the USA. 
 
At the meeting Dennis Eriksson from the Swedish University of Agricultural Science reported 
that the situation in European legislation was in limbo as EU Member States awaited a decision 
from the European Court of Justice (ECJ) regarding the regulatory status of crops generated by 
mutagenesis techniques. He suggested that there was cause for optimism following a published 
opinion from the Advocate General indicating that plants generated by GE should be regulated 
similarly to those generated by other forms of mutagenesis (Abbott 2018). However, since the 
meeting, the ECJ has now ruled that crops generated by modern mutagenesis techniques (such 
as GE) should be regulated under the 2001 GMO directive (Curia.europa.eu 2018).  This 
decision has been criticised by plant scientists as it states that assessments of crop safety 
should continue to be made on the basis of process rather than product, regardless of the safety 
of the final variety (Leyser 2018, EPSO 2018). 
  
Louise Ball from the UK Department of the Environmental and Rural Affairs (DEFRA) spoke 
positively about use of GE, and the UK Advisory Committee on Releases to the Environment 
(ACRE) has approved the application for a field trial of a gene edited Camelina sativa at 
Rothamsted Research since the meeting (Rothamsted Research 2018). In the opening line of 
its decision, ACRE ‘considers that Camelina sativa plants produced by CRISPR-Cas9 genome-
editing could have been produced through traditional breeding techniques’ (GOV UK 2018). 
This outcome indicates that UK regulators are well disposed toward the use of GE in the 
generation of novel crops. Whilst Louise Ball stated that DEFRA will take its lead from the ECJ 
decision, there may be opportunities for future use of this technology in the UK post-brexit. The 
ECJ decision does include provision for EU countries to make their own decisions on use of 
crops generated by any mutagenesis technique. Therefore, it is likely that the ruling will not be 
applied evenly across the continent.  
 
Stefan Jansson (Umea University) provided the opening keynote to the Bristol meeting, outlining 
how the Swedish Board of Agriculture does not consider GE plants any differently from those 
generated by conventional mutagenesis techniques (Eriksson D, 2018). Stefan Jansson has 
travelled through different Nordic countries to showcase the first gene-edited meal, and 
highlighted challenges that will arise if countries differently interpret the GMO directive, now 
encompassing GE plants. Whereas in Sweden the entire GE plant can be grown, in Finland only 
certain portions of the plant are permitted; whilst Norway, which is not an EU country but which 
adheres to the EU GMO directive, only allows plant GM products but not the actual plant. The 
Norwegian Biotechnology Advisory Board has recently proposed a set of regulations that would 
place all mutagenic events (including those used in conventional breeding or GE) and cisgenic 
events at a regulatory level below that used to regulate transgenic plants. Stefan pointed out 
that regulatory bodies will not be able to discriminate between CRISPR-edited and mutagenised 
plants on the basis of end-point sequence data. 
 
Light-touch regulation in the USA 
 
Professor Gary Marchant from Arizona State University reported at the meeting that in contrast 
to Europe’s process-based and heavy handed regulatory environment, the US regulatory 
environment for use of gene-edited crops is light-touch. US Department of Agriculture (USDA) 
regulation of GM crops centres on whether the plant contains any ‘plant pest DNA’, commonly 
including viral promotor sequences. If so, approval of the crop requires a laborious and 
prohibitively expensive process, stifling innovation in Small and Medium-sized enterprises 
(SMEs). However, the regulation of GE has taken a surprising twist. As transgene-free GE 
organisms do not contain plant pest DNA, they cannot be regulated by the USDA, and equally 
do not fall under the regulatory auspices of any other US regulatory agency such as the Food 
and Drug Administration (FDA) and the Environmental Protection Agency, (EPA). 
 
A growing number of gene edited plants has now been approved by the USDA, following 
verification that they contain no transgenic DNA (USDA 2018). This rapid approval process 
might appear attractive to scientists who want to quickly bring products to market, but the 
consensus from meeting delegates was that risk and evidence-based regulations are preferable 
to very light touch or no regulation (Emily Waltz 2018). If the US regulatory position is taken to 
its logical conclusion, then a GE plant that generates a known toxin could be approved as it 
does not contain ‘plant pest DNA’. Therefore, a product that has had little testing may generate 
unforeseen harmful by-products, which could damage future use of this technology and 
compromise public confidence. Gary conceded that in the USA, this issue is likely to remain 
unresolved in the near term. 
 
As trading nations take different stances regarding the growth and use of GE crops, and it may 
be impossible to discriminate between GE crops and crops that have been have engineered by 
mutagenesis or bred by conventional methods, it is likely that cross-border regulation of these 
products will be unworkable and unenforceable. 
 
Technical considerations relating to gene editing 
 
Removal of transformation bottlenecks  
 
Irrespective of the above regulatory uncertainty, GE technology provides an unsurpassed 
opportunity to modify gene function. Transformation of many crops occurs at low efficiency, and 
many other plants are recalcitrant to genetic transformation. GE has potential to obviate the 
requirement for genomic transgene integration in the production of stable mutant lines.  Whilst 
DNA delivery into plant cells is a bottleneck in GE, a few speakers reported progress in 
removing this bottleneck. Heather Whitney at the University of Bristol gave an enlightening talk 
on carbon nanodots, which are easy to make, non-toxic and can be functionalised to deliver 
DNA into plant cells. Her lab and colleagues at Bristol are currently trialling use of this 
technology to express Cas9 and sgRNAs in a range of grass crops including wheat, and there is 
exciting potential for broad application across the plant tree of life. 
 
Choun-Sea Lin travelled from Taiwan to discuss a protoplast transformation technique that has 
shifted the bottleneck in generating mutants from DNA delivery into cells and  transformation to 
efficienct regeneration in tissue culture. He discussed polyethylene glycol delivery of DNA into 
protoplasts, regeneration and editing of 11 species (5 grasses, 4 brassicas, and 2 nightshades) 
and has developed methods to screen individual protoplasts for edits (Figure 1, Lin et al., 2018). 
Choun-Sea’s group is eager to use their expertise on an expanded number of plant species and 
welcomes collaboration. 
 
Best practice in construct design 
 
Although many labs are using CRISPR, best practice is not yet fully established. Baptiste Castel 
from Jonathan Jones’ lab at The Sainsbury lab, Norwich presented a comprehensive 
assessment of the molecular parameters for using the CRISPR system in Arabidopsis. Their lab 
has determined that either UBI10, YAO or RPS5 promotor-induced expression of a plant-
optimised Cas9_3, which includes an internal intron, caused the highest mutation rates. In 
addition they produced a more efficient ‘extension-flip’ variety of the guideRNA. Finally when the 
Cas9 and guideRNA were positioned head-to-head within a T-DNA, they could isolate more 
stably edited plants in the T1 generation (Figure 2).  
 
Michaela McGinn (Illinois State University) reported that, in the novel oilseed feedstock crop 
Pennycress, the source of the Cas9 nuclease partially determined editing efficiency. She found 
that Staphylococcus aureus Cas9 had higher editing rates than Staphylococcus pyogenes 
Cas9, and that Cas9 expression levels as determined by western blot were not predictive of 
editing efficiency for either nuclease. 
 
Screening 
 
Michaela McGinn also reported that edits did not always appear in or stabilise in the T1 
generation, sometimes appearing in T2 or later generations. Thus, transformed plants that 
initially showed WT gene activity may in fact generate de novo edits that result in mutant 
phenotypes in the T2 generation (Figure 3). Such edits were detectable in sequence traces from 
T1 GE plants, and trace analysis was therefore recommended. Michaela had used CRISPR-
Cas9 to reduce the levels of an undesired fatty acid from 40% in wild-type Pennycress seed to 
less than 1% in GE mutants (McGinn et al 2018)÷ . 
 
A potential concern with the use of CRISPR-Cas9 to create new crop varieties involves the 
generation of off-target edits across the genome. To allay these concerns, Yiping Qi from the 
University of Maryland described a remarkable set of experiments that involved conducting 
whole genome sequencing on almost 70 individual rice plants (Tang et al., 2018). This allowed 
them to assess the amount of spontaneous mutations in unedited plants in comparison with 
those that had been edited by either Cas9 or Cpf1 nucleases. Yiping Qi showed that any allele 
changes could be explained by the rate of spontaneous mutations and that neither of the 
nucleases induced additional off-target mutations in the T1 generation. 
 
Given the technical challenges of GE, it might be more cost-effective for researchers to engage 
with a community resource, and a number were introduced throughout the meeting. These 
include facilities at the National Institute for Agricultural Biology, Cambridge, the University of 
Bristol, Rothamsted Research, the John Innes Centre and the Vienna Biocenter Core Facility. 
Each facility welcomes prospective collaborations. 
 
Novel applications of gene editing nucleases 
 
Whilst the meeting focussed on GE, novel uses for Cas9 gene targeting were also discussed. 
Alex Leydon from Jennifer Nemhauser’s group at the University of Washington in using 
repurposed nucleases for transcriptional control. The synthetic HACR protein includes a dCas9 
that binds DNA but lacks nuclease activity, a transcriptional repression domain and a hormone-
inducible degron (Khakhar et al., 2018). By either replacing the repression domain and/or the 
degron, the HACR system can provide enormous variation in experimental design. The core 
dCas9 subunit allows tight gene regulation, and the Nemhauser group has used different 
degrons to generate a set of hormone biosensors that are responsive to auxin, jasmonate or 
gibberellic acid (GA). Although at the workshop Alex specifically described research that had 
modeled the response to GA, enormous potential of the HACR system was clear. 
  
Conclusion 
 
This meeting introduced a wide range of projects that are using CRISPR-based GE and 
highlighted attempts to optimise GE technology. The community is progressing towards the 
establishment of a set of standardised protocols that will reduce challenges for new users.  
Rarely has the future use of a technology been so tightly linked to its regulation and this meeting 
highlighted the policies employed by different countries. Although a global consensus for 
evidence- and trait-based regulation of gene edited crops seems some way off, differences in 
how countries apply these rules will hopefully mean that the technology can still be used to 
develop useful and much needed novel varieties.  
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Figure Legends 
 
 
Figure 1: Assessing gene editing in single isolated protoplasts. 
Protoplasts were released from a single leaf and diluted to a concentration of 1 cell/ul. Following 
DNA delivery, screening involved two rounds of PCR and dCAPs analysis to detect gene edited 
alleles, or plants were regenerated. Adapted from Choun-Sea Lin from the Academica Sinica, 
Taipei. 
 
Figure 2: Optimised CRISPR-Cas9 system for gene editing in Arabidopsis.  
A: Gene editing construct design favoured by Baptiste Castel from The Sainsbury lab, Norwich. 
 
Figure 3: Scoring a sequencing trace from T1 gene edited plants.  
Traces from top down:  
A: a true wildtype sequence with the Staphylococcus pyogenes Cas9 NGG PAM site boxed in 
red. B” a ‘wildtype’ sequence with low level editing activity indicative of stable indels in 
subsequent generations. C: a heterozygous Cas9 generated edit. D: a homozygous edit (+A 
insertion event). E: a bi-allelic edit from two independent editing events in a single generation.  
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